Recombinant allergen-specific antibody fragments: tools for diagnosis, prevention and therapy of type I allergy.
Type I allergy represents a hypersensitivity occurring in almost 20% of the population that is based on the recognition of innocuous airborn antigens (pollen, mite, mould and pet allergens) by specific immunoglobulin E. Allergic symptoms (e.g. allergic rhinitis, conjunctivitis, asthma) are caused by...
Main Authors: | Valenta, R, Flicker, S, Eibensteiner, P, Steinberger, P, Laffer, S, Dolecek, C, Kraft, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1997
|
Similar Items
-
Cloning allergen-specific antibody fragments (Fabs); tools for allergen standardization and therapy of type I allergy.
by: Valenta, R, et al.
Published: (1997) -
Allergen-antibody interactions: Molecular approaches for specific therapy of type I allergy
by: Valenta, R, et al.
Published: (1995) -
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.
by: Valenta, R, et al.
Published: (1998) -
Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens.
by: Dolecek, C, et al.
Published: (1995) -
Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergen.
by: Dolecek, C, et al.
Published: (1993)